Skip to content
Zelmic Logo
Zelmic Logo
  • About
    • QUALITY & COMPLIANCE
    • MANAGEMENT TEAM
  • Why Zelmic
    • Product development
    • Analytical chemistry
    • Performance testing (IVRT & IVPT)
  • Topical generics
  • News & events
  • Contact
  • WHY ZELMIC
  • Development services
    • Product development
    • IMP GMP MANUFACTURING
    • Analytical chemistry (GMP)
    • Performance testing (IVRT & IVPT)
  • Topical generics
  • About
  • News & events
  • Contact

Category: Uncategorized

May 13, 2022November 7, 2024

Zelmic will attend the upcoming Skin Forum 2022 in Malmö, Sweden.

Ph.D. Anna Runnsjö will be present at the upcoming Skin Forum 2022 in Malmö, Sweden.

Continue Reading
November 23, 2021November 7, 2024

Zelmic AB to Participate in Upcoming Pharma Outscouring 2021

Pharma Outscouring 2021

Continue Reading
August 17, 2021December 15, 2021

The Future of Swedish and Danish Life Science 2021

Zelmic will attend The Future of Swedish and Danish Life Science on the 2nd of September. David Sagna, CEO, and Ph.D. Susanne Nilsson, Head of Development will be present at the event.

Continue Reading
April 14, 2021August 17, 2021

Zelmic AB will attend the 8th NLSDays digital event 2021

David Sagna, CEO and Ph. D Susanne Nilsson, Head of Development, will be present during the event this year.

Continue Reading
January 7, 2021April 14, 2021

Annual Dermatology Drug Development Summit 2021

MEET US AT 2nd Annual Dermatology Drug Development Summit 2021, 17-19 February, Virtual Event | 9AM – 5PM CET.

Continue Reading
March 7, 2020February 24, 2021

Supporting clients through COVID-19

We are fortunate to be able to remain open and to assist and support our clients’ needs during the fight against COVID-19.

Continue Reading
January 25, 2020February 24, 2021

GMP Certified

We are now GMP certified by the Swedish Medical Products Agency! We are happy to announce a successfully implementation of a new QMS system at Zelmic…

Continue Reading
November 25, 2019February 24, 2021

Two new colleagues join the team

We are welcoming Susanne Nilsson and Ulf Larsson how have joined the team at Zelmic…

Continue Reading

Posts navigation

Newer posts

Recent Posts

  • Case study — A stable triple-API topical, from development to a successful First-in-Human study
  • Strengthening Oligonucleotide Capabilities: Zelmic Invests in Advanced UHPLC Technology
  • Happy Holidays from Zelmic – Reflecting on a Year of Growth and Collaboration
  • Great Collaboration and Important Update as TIRmed Pharma Strengthens Partnership with Zelmic
  • Zelmic at NLSDays 2025 – Connecting Science, Formulation, and Clinical Innovation in Gothenburg

Recent Comments

    Archives

    • August 2026
    • March 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • June 2025
    • March 2025
    • January 2025
    • November 2024
    • September 2024
    • July 2024
    • November 2023
    • August 2023
    • May 2023
    • February 2023
    • October 2022
    • September 2022
    • August 2022
    • May 2022
    • November 2021
    • August 2021
    • April 2021
    • January 2021
    • March 2020
    • January 2020
    • November 2019

    Categories

    • frontpage
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Sitemap

    • Home
    • Why Zelmic
    • Development services
    • Product development
    • IMP GMP Manufacture
    • Analytical chemistry (GMP)
    • Performance testing
    • Topical generics
    • About
    • Contact
    • FAQ
    • News & events
    • Privacy policy
    • Whistleblower

    Contact us

    Zelmic AB

    Sankt Lars väg 45 B

    SE-222 70 Lund

    Sweden

    Phone+46 4616 12 40

    Emailinfo@zelmic.se

    LinkedIn

    Zelmic AB

    Zelmic AB is a CRO specialized
    in topical delivery of
    pharmaceuticals

    Part of CTR group

    CTR group

    © 2026, All rights reserved: Zelmic AB

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK